6 Cheapest Zepbound Options (2026)

The cheapest way to get Zepbound right now, ranked

None of these six prices are hypothetical — every one is a real, dated figure from the provider's own current pricing, cross-checked against at least one independent source. What separates them isn't shopping savvy so much as which category you fall into before you even open a browser. Are you commercially insured with Zepbound as a covered benefit? Uninsured entirely? Working with a telehealth company that bundles the drug into a membership? Each answer routes you to a different rung on the ladder above, and the gap between the top and bottom rungs is enormous — roughly $25 a month at one end, north of $1,000 at the other, for the identical KwikPen.

The ranking above reflects the real ongoing monthly cost, not a teaser rate that climbs later. Two rungs deserve a closer look before you pick one: the Savings Card, because it only pays off if your plan actually treats Zepbound as covered, and LillyDirect's own self-pay ladder, because it's the floor almost everyone uninsured should be comparing every other offer against.

Cheapest if insurance covers Zepbound: the Savings Card route

If your commercial plan already lists Zepbound as a covered drug, nothing else on this page comes close. Lilly's manufacturer Savings Card brings a fill down to roughly $25 a month for eligible patients, with the program capping the discount at around $100 off per fill and $1,300 for the year, usable across up to 13 fills. The card is set to expire December 31, 2026, so re-check the terms if you're reading this deep into the year.

The card also has a second, less-advertised use: if your plan technically covers weight-management drugs but excludes Zepbound by name, enrolling still routes you to the same self-pay tiers described below rather than full list price — worth doing even if you assume you won't qualify for the best rate. Some current reporting cites a flat non-covered tier closer to $499 a month for that scenario rather than the $299–$449 self-pay ladder; the two figures may reflect different card versions, so confirm which applies to your specific plan at zepbound.lilly.com/savings before assuming either number.

One more path opened up this month for a specific group: Medicare's new GLP-1 Bridge demonstration began covering the Zepbound KwikPen on July 1, 2026, capping eligible beneficiaries' cost near $50 a month. It's brand new, runs only through the end of 2027, and covers the KwikPen specifically rather than vials — worth asking your plan about directly if you're on Medicare, rather than assuming the retail or self-pay numbers apply to you.

Cheapest if you're uninsured or Zepbound isn't covered: LillyDirect self-pay, dose by dose

This is the number worth memorizing if you don't have insurance, or your plan simply won't pay toward Zepbound: Lilly sells it directly to self-pay patients through LillyDirect at $299 a month for the 2.5mg starter dose, $399 at 5mg, and a flat $449 across every dose from 7.5mg through 15mg. Both the single-dose vial and the KwikPen autoinjector sit on that same ladder now — the format is a comfort choice, not a price one.

The one rule worth building a habit around: the discount only holds if your next refill ships within 45 days of your prior delivery date, not your order date. Miss it and the price resets higher for that fill. The full mechanics of that clock, plus a deeper vial-versus-pen walkthrough, live on Zepbound without insurance if you want the complete rundown.

Zepbound through telehealth partners — cheaper, or just another markup?

A handful of telehealth companies will get you a Zepbound prescription and route your medication through the same LillyDirect pricing described above. The honest question is what they charge on top of that, and the answer varies a lot by company.

PlushCare — best for insured women who want it folded into primary care

PlushCare doesn't reprice the medication; Zepbound still runs $299 to $449 a month by dose through the same self-pay ladder. What PlushCare adds is the clinical visit, and it's structured around insurance rather than a flat membership: in-network with major carriers like Aetna, Cigna, and BCBS, with visit copays commonly $30 or less. Uninsured, expect a $129 first visit and roughly $99 for follow-ups. A $19.99-a-month membership exists for faster scheduling and messaging, but it's optional — you can see a clinician and get a prescription without it, which isn't true everywhere.

For a woman whose plan actually covers the visit even if it doesn't cover the drug, that structure can shave a real amount off the year without adding a second subscription to track.

Ro — best for bundled labs, worst for the sticker price

Ro takes the opposite approach: a required $145-a-month Ro Body membership, which includes labs, coaching, and insurance-navigation help, stacked on top of the same $299–$449 Zepbound medication price. Add them and the real all-in cost lands somewhere between roughly $444 and $594 a month — noticeably more than going to LillyDirect directly for the drug and handling the clinical piece elsewhere. What you get for the extra membership fee is routine lab monitoring folded in at no separate charge and staff who'll pursue prior authorization on your behalf, which has real value if your insurance situation is genuinely unclear and you'd rather not sort it out alone.

If labs and hand-holding aren't worth $145 a month to you, Ro is not the cheap option on this page — it's the one that trades cost for services bundled in.

LifeMD — a connector, not an independent price

LifeMD is a publicly traded telehealth company that prescribes Zepbound and checks insurance benefits, but it doesn't set its own medication price the way a compounding pharmacy does. There's a membership fee for the clinical program itself, and separately, the drug — for cash-pay patients, that medication charge runs on the same LillyDirect self-pay ladder described above rather than a LifeMD-specific rate. Ask for the membership fee and medication price broken out as two separate numbers before you enroll, rather than anchoring on whichever figure the landing page shows first.

Cheapest pharmacy for Zepbound: does GoodRx or SingleCare beat LillyDirect?

Usually, no — and this is the gap that trips people up most. A live check of GoodRx's own pricing page shows Zepbound coupon prices starting around $995 a month, against an average cash price near $1,271 at a standard pharmacy. That's a real discount off list, but it's still more than double LillyDirect's highest self-pay tier. The reason is contractual, not incompetence on GoodRx's part: Lilly's agreements with third-party discount-card programs keep the markdown on a patented, no-generic brand shallow, so a coupon price frequently lands close to the pharmacy's regular cash rate rather than a meaningful cut.

GoodRx does offer one path worth knowing about separately: its own Care Direct telehealth membership can connect you to Zepbound KwikPens priced at the same $299 LillyDirect starting tier, plus roughly $39 a month for the membership itself. That's still slightly more than enrolling with LillyDirect directly and skipping the added membership fee entirely — worth comparing both before you assume the GoodRx-branded path is the discount.

Is there a cheaper alternative to Zepbound? Compounded tirzepatide and its legal status

The cheapest number on this whole page belongs to a different product. Compounded tirzepatide, sold through telehealth providers like Curex from about $199 a month all-in, is the same active molecule as Zepbound, but it's mixed by a licensed 503A pharmacy rather than manufactured and FDA-approved as a finished drug the way Zepbound is. That distinction is worth sitting with before treating the lower number as simply a discount on the same thing.

The legal ground shifted hard in 2025. Once the FDA declared the tirzepatide shortage resolved, the broad compounding that fueled a wave of cheap telehealth tirzepatide lost its basis; enforcement discretion for 503B outsourcing facilities ended in March 2025. What remains is narrower: a 503A pharmacy can still compound tirzepatide for a specific patient when a prescriber documents a clinical reason the approved product doesn't meet — cost alone isn't that reason under current FDA guidance, even though cost is why most people are drawn to it. Layered on top, the FDA proposed in an April 2026 announcement to exclude tirzepatide from the 503B bulk-substances list entirely; as of this writing that comment period remains open through July 30, 2026, with no final rule yet issued.

None of that makes compounded tirzepatide illegal outright — the narrow 503A pathway is real and still operating — but it does mean the $199 price and the $299 LillyDirect price aren't really competing on a level field. One is an approved brand with a manufacturer behind it; the other rests on a legal exception that's actively being narrowed. For the full provider-by-provider breakdown of that market, see cheapest tirzepatide providers.

How the 'cheapest' price is actually calculated

A single advertised number rarely tells you what you'll actually pay across a year. A few mechanics decide that more than the sticker price does.

• Dose tier — LillyDirect's price rises with dose only up to 5mg; from 7.5mg through the top 15mg maintenance dose, the self-pay price is flat at $449, so titrating up doesn't cost more past that point.
• The 45-day refill window — the clock starts at your delivery date, not your order date. Miss it and the price resets to a higher, non-discounted rate for that fill.
• Membership stacking — Ro and, to a lesser extent, PlushCare's optional add-on layer a separate monthly fee on top of the identical medication price; always add the two together before comparing across providers.
• Coupon shallow-discounting — GoodRx and SingleCare prices on a patented brand like Zepbound are contractually limited in how deep they can cut, which is why the coupon rarely beats the manufacturer's own self-pay program.
• Insurance status — this decides more of your final number than any other single factor. A covered plan with the Savings Card and an uncovered plan on the same card can differ by hundreds of dollars a month.

Annual cost math: what shopping cheap actually saves you

Monthly figures understate the stakes. Run the same six routes across a full year and the gap turns from noticeable to enormous.

• Savings Card, insured and covered: about $300 a year
• LillyDirect self-pay, uninsured: about $3,588 a year at the 2.5mg starter dose, rising to about $5,388 a year at maintenance doses of 7.5mg and above
• PlushCare, cash-pay: roughly the same $3,588–$5,388 medication cost, plus a few hundred dollars a year in visit fees
• Ro, all-in with membership: roughly $5,328 to $7,128 a year
• GoodRx/SingleCare retail coupon: roughly $11,940 to $13,080 a year
• Compounded tirzepatide (different product), Curex starter rate: about $2,388 a year

The distance between the best-case insured year and the uncovered-retail year runs into the thousands of dollars — which is the real argument for confirming your coverage and Savings Card eligibility before your first fill, not after a few months of paying the wrong price by accident.

Red flags: when a cheap Zepbound price is too good to be true

A few patterns are worth treating as hard stops rather than lucky finds. Any seller offering Zepbound or tirzepatide without a prescription or a clinician evaluation isn't operating legally, and that's a real counterfeit and dosing-error risk. Brand-name Zepbound priced meaningfully below the $299 LillyDirect floor is a sign you're not looking at the real product — that floor is Lilly's own manufacturer rate, and nobody legitimately undercuts it. And for compounded providers specifically, a legitimate one should be able to name the 503A pharmacy that fills the prescription and explain how your specific clinical need for compounding is documented — not just point to price as the reason.